Cargando…

d‐Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model

BACKGROUND: Patients with unprovoked venous thromboembolism (VTE) can be stratified according to their recurrence risk based on their sex, the VTE location, and d‐dimer measured 3 weeks after anticoagulation by the Vienna Prediction Model. We aimed to expand the model to also assess the recurrence r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eichinger, Sabine, Heinze, Georg, Kyrle, Paul A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959721/ https://www.ncbi.nlm.nih.gov/pubmed/24385451 http://dx.doi.org/10.1161/JAHA.113.000467

Ejemplares similares

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study
por: Traby, Ludwig, et al.
Publicado: (2012)

Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study
por: Eischer, Lisbeth, et al.
Publicado: (2012)

Risk of venous thromboembolism during rehabilitation of patients with spinal cord injury
por: Eichinger, Sabine, et al.
Publicado: (2018)

Effectiveness of D-Dimer as a Screening Test for Venous Thromboembolism: An Update
por: Pulivarthi, Swaroopa, et al.
Publicado: (2014)

Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
por: Douketis, James, et al.
Publicado: (2011)

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
por: Khan, Faizan, et al.
Publicado: (2019)

Systematic testing for venous thromboembolism in hospitalized patients with COVID-19 and raised D-dimer levels
por: Weinberg, Ido, et al.
Publicado: (2021)

Diagnostic Value of Elevated D-Dimer Level in Venous Thromboembolism in Patients With Acute or Subacute Brain Lesions
por: Kim, Yeon Jin, et al.
Publicado: (2015)

Age-adjusted d-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

The value of blood D-dimer test in the diagnosis of walk-in patients with venous thromboembolism
por: Yasuoka, Shozo, et al.
Publicado: (2011)

Novel screening criteria for post‐traumatic venous thromboembolism by using D‐dimer
por: Iyama, Keita, et al.
Publicado: (2018)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Clinical Utility of D-Dimer for Rule-Out or Rule-In of Venous Thromboembolism in Syncope
por: Badertscher, Patrick, et al.
Publicado: (2022)

Management of venous thromboembolism: an update
por: Piran, Siavash, et al.
Publicado: (2016)

Cost‐minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D‐dimer for exclusion of venous thromboembolism
por: Verma, Karan, et al.
Publicado: (2017)

Cutoff Values of Plasma D-Dimer Level in Patients with Diagnosis of the Venous Thromboembolism after Elective Spinal Surgery
por: Hamidi, Saeed, et al.
Publicado: (2015)

Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients
por: Roncon, Loris, et al.
Publicado: (2020)

Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Klok, Frederikus A., et al.
Publicado: (2019)

Accuracy of D-Dimers to Rule Out Venous Thromboembolism Events across Age Categories
por: Der Sahakian, G., et al.
Publicado: (2010)

D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism
por: Imberti, D.
Publicado: (2007)

Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism
por: Han, Donghee, et al.
Publicado: (2016)

Highly Elevated Quantitative D-Dimer Assay Values Increase the Likelihood of Venous Thromboembolism
por: Francis, Samuel, et al.
Publicado: (2019)

Updated recommendations for the treatment of venous thromboembolism
por: Hong, Junshik, et al.
Publicado: (2021)

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Jara-Palomares, Luis, et al.
Publicado: (2019)

D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants
por: Legnani, Cristina, et al.
Publicado: (2019)

Reply to the authors of “Age-adjusted D-dimer cut-off levels to exclude venous thromboembolism in COVID-19 patients”()
por: Godon, Alexandre, et al.
Publicado: (2021)

The prediction role of D-dimer in recurrence of venous thromboembolism 1-year after anticoagulation discontinuing following idiopathic deep vein thrombosis
por: Tamizifar, Babak, et al.
Publicado: (2014)

Venous thromboembolism in patients with COVID-19 and correlation with D-dimers: a single-centre experience
por: Khan, Muhammad Ziaullah, et al.
Publicado: (2020)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Uncertainties on the prognostic value of admission D‐dimer on venous thromboembolism occurrence in patients with COVID‐19
por: Zhang, Litao, et al.
Publicado: (2022)

Arterial thromboembolism associated with COVID-19 and elevated D-dimer levels
por: Garg, Karan, et al.
Publicado: (2020)

Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update
por: Akrivou, Dimitra, et al.
Publicado: (2022)

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study
por: Moik, Florian, et al.
Publicado: (2020)

The Predictive Value of d-Dimer Test for Venous Thromboembolism During Puerperium: A Prospective Cohort Study
por: Hu, Wen, et al.
Publicado: (2020)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review
por: Price, Christopher P., et al.
Publicado: (2020)

D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis
por: Bellesini, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ajg0p9rp7p1rbj3m18kkp62klm